Quantitative study of tiantai I on superoxidative dismutase and lipofuscin in relevant cerebral areas of spontaneous Alzheimer disease in mice

Chinese Journal of Clinical Rehabilitation

Volumn 9, Issue 13, 2005, Pages 178-181

  Wu, Zheng Zhi ^a   Li, Ming ^a   Li, Yao Fang ^a   Zhang, Yong Feng ^a   Jia, Xiu Qin ^a   Chen, Man Yin ^a  

^a Institute of Combination of Traditional Chinese Medicine and Western Medicine of Shenzhen   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; DIHYDROERGOTOXINE MESILATE; FREE RADICAL; HERBACEOUS AGENT; LIPOFUSCIN; SUPEROXIDE DISMUTASE; TIANTAI I; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; BRAIN TISSUE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DOSE REGIMEN; ENZYME ACTIVITY; FROZEN SECTION; HIPPOCAMPUS; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LEARNING DISORDER; MALE; MEMORY DISORDER; MOUSE; NONHUMAN; PHARMACODYNAMICS; QUANTITATIVE ANALYSIS; RANDOMIZATION; SCORING SYSTEM; TRANSMISSION ELECTRON MICROSCOPY;

EID: 27644465392     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sadik K, Wilcock G. The increasing burden of Alzheimer disease. Alzheimer Dis Assoc Disord 2003; 17 Suppl 3: S75-9
2. Henderson AS. The risk factors for Alzheimer's disease: a review and a hypothesis. Acta Psychiatr Scand 1988; 78(3): 257-75
3. Harman D, Hendricks S, Eddy DE, et al. Free radical theory of aging: effect of dietary fat on central nervous system function. J Am Geriatr Soc 1976; 24(7): 301-7
4. Smith MA, Sayre LM, Anderson VE, et al. Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2, 4-dinitrophenylhydrazine. J Histochem Cytochem 1998; 46(6): 731-5
5. Cai YM, Xue RL, Li W, et al. Effects of global ischemia/reperfusion on oxygen free radicals and edothelin in rats. Zhongguo Linchuang Kangfu 2004; 8(4): 656-7
6. Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 1997; 23(1): 134-47
7. Neely MD, Sidell KR, Graham DG, et al. The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin. J Neurochem 1999; 72(6): 2323-33
8. Behl C. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches. Prog Neurobiol 1999; 57(3): 301-23
9. Gallagher M. Animal models of memory impairment. Philos Trans R Soc Lond B Biol Sci 1997; 352(1362): 1711-7
10. Phinney AL, Home P, Yang J, et al. Mouse models of Alzheimer's disease: the long and filamentous road. Neurol Res 2003; 25(6): 590-600
11. Gallagher M, Bizon JL, Hoyt EC, et al. Effects of aging on the hippocampal formation in a naturally occurring animal model of mild cognitive impairment. Exp Gerontol 2003; 38(1-2): 71-7
12. Liu DK, Zuo J. Progression on pathology, biochemics and pharmacotherapeutics of Alzheimer's disease. Linchuang Shenjingbingxue Zazhi 1998; 11(3): 188-91
13. Wang BY, Li YS, Huang GS, et al. Pathology Technic. Beijing: People's Medical Publishing House 2000: 418-37
14. Qiu Y, DU GH, QU ZW, et al. Establishment of mice model of temporal cerebral ischemia seizure causing learning and memory disorder and the protection of panaxoside. Zhongguo Yaolixue Tongbao 1995; 11(4): 299-302
15. Huang X, Moir RD, Tanzi RE, et al. Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann N Y Acad Sci 2004; 1012: 153-63
16. Mark RJ, Blanc EM, Mattson MP. Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease. Mol Neurobiol 1996; 12(3): 211-24
17. 2+ / ascorbate-dependent oxidation of Alzheimer's disease beta-amyloid peptides. Ann N Y Acad Sci 2004; 1012: 164-70
18. Cotman CW, Su JH. Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol 1996; 6(4): 493-506
19. Peskind ER. Neurobiology of Alzheimer's disease. J Clin Psychiatry 1996, 57 Suppl 14: 5-8
20. Schapira AH. Oxidative stress and mitochondrial dysfunction in neurodegeneration. Curr Opin Neurol 1996; 9(4): 260-4
21. Bracco F, Scarps M, Rigo A, et al. Determination of superoxide dismutase activity by the polarographic method of catalytic currents in the cerebrospinal fluid of aging brain and neurologic degenerative diseases. Proc Soc Exp Biol Med 1991; 196(1): 36-41
22. Liu Q, Raina AK, Smith MA, et al. Hydroxynonenal, toxic carbonyls, and Alzheimer disease. Mol Aspects Med 2003; 24(4-5): 305-13
23. Pogocki D. Alzheimer's beta-amyloid peptide as a source of neurotoxic free radicals: the role of structural effects. Acta Neurobiol Exp (Wars) 2003; 63(2): 131-45
24. Kar S, Quirion R. Amyloid beta peptides and central cholinergic neurons: functional interrelationship and relevance to Alzheimer's disease pathology. Prog Brain Res 2004; 145: 261-74
25. Smith MA, Nunomura A, Zhu X, et al. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. Antioxid Redox Signal 2000; 2(3): 413-20
26. Wu ZZ, Tang CY, Lu HP, et al. Effects of Tiantai No. 1 on Cognitive Ability and Subtype of M-Cholinergic Receptor in Aged Dementia Mice. Zhongguo Yiyao Xuebao 1999; 14(2): 18-20
27. Wu ZZ, Tang CY, Lu HP, et al. Effects of BUGANWENDAN Formula on Learning, Memory and Subtype of M-Cholinergic Receptor in Aged Dementia Mice. Zhongguo Zhongyiyao Keji 1998; 5(4): 223-5
28. Butterfield DA, Castegna A, Lauderback CM, et al. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 2002; 23(5): 655-64
29. Ghiso J, Frangione B. Amyloidosis and Alzheimer's disease. Adv Drug Deliv Rev 2002; 54(12): 1539-51
30. Li F, Calingasan NY, Yu F, et al. Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J Neurochem 2004; 89(5): 1308-12